Be in the know. 18 key reads for Thursday…

  1. China Markets Are Hot Again as Traders Bet on More Policy Easing (bloomberg)
  2. China’s Credit Growth Rebounds in November After Slowdown (bloomberg)
  3. Biotech Has Been Crushed: 5 Stocks to Buy Now That Pay Big Dividends (247wallst)
  4. FDA Authorizes AstraZeneca Drug to Prevent Covid. It’s an Alternative to Vaccines for Some. (barrons)
  5. Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash (barrons)
  6. CVS Boosts Its Earnings Outlook and Dividend Payout. (barrons)
  7. The Bond Market Is Watching for a Fed Mistake. Check the Yield Curve. (barrons)
  8. Credit Suisse boosts S&P 500 target, citing strong economy and stalling stimulus legislation (marketwatch)
  9. Beijing Reins In China’s Central Bank (wsj)
  10. Fewer Americans quit their jobs in October as openings rose again (nypost)
  11. S. Jobless Claims Decline to Lowest Level Since 1969 (bloomberg)
  12. China Is Slamming Shut Its Window of Opportunity (bloomberg)
  13. Joe Manchin sounds fed up with Biden’s spending plans: ‘We’ve done everything that we can to help people’ (businessinsider)
  14. Hormel reports record sales (marketwatch)
  15. China Evergrande Defaults on Its Debt. Now What? (nytimes)
  16. China’s Central Bank Is Under Pressure, But to What End? (wsj)
  17. Alibaba Stock Looks Like a Screaming Buy. Jump in at Your Own Risk. (barrons)
  18. Economists predict complete ‘taper’ of Fed bond buying by end of March (ft)